Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors

Clinical trial NCT00019630 · COMPLETED

Trial details

NCT number: NCT00019630
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Childhood Soft Tissue Sarcoma Childhood Liver Cancer Bone Cancer Brain Tumor Kidney Tumor

Start date: 1999-07-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.